PPA
HARP

Parametric Portfolio Associates’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Parametric Portfolio Associates’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,950
Closed -$147K – 3790
2021
Q4 		$147K Buy
1,950
+749
+62% +$51.1K ﹤0.01% 3486
2021
Q3 		$95K Buy
1,201
+150
+14% +$15.1K ﹤0.01% 3541
2021
Q2 		$146K Buy
+1,051
New +$201K ﹤0.01% 3455

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Parametric Portfolio Associates's HARP Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2022, closing a stake of 1,950 shares — an estimated $147K sold.

Parametric Portfolio Associates first reported a position in HARP in Q2 2021 and held it in 3 quarters. The position peaked at $147K in Q4 2021. 79 funds tracked by Wall St. Rank hold HARP as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,950 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $147K.
  • Parametric Portfolio Associates first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Parametric Portfolio Associates's Harpoon Therapeutics, Inc. Common Stock position peaked at $147K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.